Results 91 to 100 of about 61,846 (265)

Comparison of oral prednisolone pulse therapy with intravenous methylprednisolone pulse therapy in severe alopecia areata [PDF]

, 2013
Objective: To compare the efficacy of oral prednisolone pulse therapy in comparison to the intravenous methylprednisolone pulse therapy in treatment of severe alopecia areata. Patients and methods: In this interventional study, all patients with alopecia
Alborzi, A., Dehghan, A., Shahini, N.
core  

DYSPEPSIA AND HEARTBURN

Rheumatic Disease Clinics of North America, 1999
Dyspepsia and heartburn are the two cardinal symptoms of foregut dysfunction. When confronting such a problem, that physician must first learn to discern between the two, because treatment can be quite different for the conditions presenting with these symptoms.
N A, Ahmad, D C, Metz
openaire   +2 more sources

Visual Findings and Reported Symptoms Do Not Correlate With Laryngopharyngeal Reflux, Underscoring the Need for Confirmatory Diagnostics

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
ABSTRACT Objective To assess the correlation between hypopharyngeal acid exposure, symptom questionnaires, and pharyngeal findings in patients with suspected laryngopharyngeal reflux (LPR) and to provide normative data for hypopharyngeal acid reflux in healthy Finnish subjects.
Markku Patjas, Anthony Maalouf, Pia Järvenpää, Timo Mustonen, Teemu Kinnari, Ahmed Geneid   +5 more
wiley   +1 more source

Options for optimizing treatment of gastroesophageal reflux disease with proton pump inhibitors

Медицинский совет, 2015
Proton pump inhibitors (PPI) were successfully used for the treatment of acid-base disorders, in particular GERD, for the past 20 years. However, approximately 30% of patients with gastroesophageal reflux disease (GERD) do not adequately respond to ...
M. F. Osipenko, E. A. Bikbulatova, S. I. Kholin   +2 more
doaj   +1 more source

Foregut microbiome in development of esophageal adenocarcinoma [PDF]

, 2010
Esophageal adenocarcinoma (EA), the type of cancer linked to heartburn due to gastroesophageal reflux diseases (GERD), has increased six fold in the past 30 years. This cannot currently be explained by the usual environmental or by host genetic factors.
Aaron Tenney, Carlos W. Nossa, Daniel Brami, Eoin L. Brodie, Erika Gerz, Fritz Francois, Gary L. Andersen, Indresh K. Singh, Karen E. Nelson, Les Foster, Liying Yang, Manolito Torralba, Mathangi Thiagarajan, Mengling Liu, Michael Poles, Monika Bihan, Morris Traube, Navjeet Singh, Pinak Shah, Shibu Yooseph, Stuart M. Brown, Sukhleen Bedi, Tamasha Parsons, Todd Z. DeSantis, William E. Oberdorf, Yu Chen, Yu-Hui Rogers, Zhiheng Pei   +27 more
core   +2 more sources

Prevalence and Predisposing Factors of Helicobacter pylori Infection in Symptomatic Patients: A Multicenter Study in Ghana's Upper East Region

Public Health Challenges, Volume 5, Issue 2, June 2026.
A high Helicobacter pylori prevalence of 65.8% was detected among dyspeptic patients in northern Ghana, linked to poor sanitation, use of public toilets, consumption of street‐vended food, and drinking untreated water. These findings underscore the need for targeted public‐health interventions. ABSTRACT Background Helicobacter pylori (H.
Elvis Ramsy Awuni, Maxwell Akonde, Benedict Boateng Antuamwine   +2 more
wiley   +1 more source

Advantages of alginate and PPI combination in relief of heartburn and regurgitation during the first days of treatment of gastroesophageal reflux disease

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2015
Aim of investigation. To estimate advantages of combined intake of proton pump inhibitor (PPI) and alginate in comparison to monotherapy by PPI in terms of symptom relief in the first days of gastroesophageal reflux disease (GERD) treatment.Material and ...
D. S. Bordin, O. B. Yanova, O. I. Berezina, Ye. V. Treyman   +3 more
doaj  

Gastric mucosal prolapse: A case of proton‐pump inhibitor nonresponsive dyspepsia

Clinical Case Reports, 2018
Key Clinical Message Gastric mucosal prolapse (GMP) is a rare clinical syndrome that in patients with hiatal hernias and gastroesophageal reflux disease (GERD) may present with typical findings of abdominal pain and reflux symptoms but prove resistant to
Tagore Sunkara, Emmanuel Ofori, Krishna Sowjanya Yarlagadda, Vinaya Gaduputi   +3 more
doaj   +1 more source

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]

, 2013
Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Arnold, Dirk, Brenner, Baruch, Galle, Peter R., Gockel, Ines, Klautke, Gunther, Lang, Hauke, Möhler, Markus, Roessler, Hans-Peter, Rödel, Claus, Schimanski, Carl Christoph, Schmidberger, Heinz, Thomaidis, Thomas, Trarbach, Tanja   +12 more
core   +1 more source

The pharmacokinetics and safety of vonoprazan in adolescents and children with gastroesophageal reflux disease

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 5, Page 1153-1161, May 2026.
Abstract Objectives Vonoprazan, a potassium‐competitive acid blocker, provides more rapid, potent, and durable elevations in gastric pH than proton pump inhibitors in adults and may be a treatment option for adolescents and children with gastroesophageal reflux disease (GERD).
Darcy J. Mulford, David A. Gremse, Yu‐Ming Chang, Eckhard Leifke, Thomas Wagner, Axel Facius, Galen Witt   +6 more
wiley   +1 more source